Ticagrelor Lowers the Risk for OA Compared with Clopidogrel
Nerve Growth Factor Inhibitor Study Highlights Promise as an OA Pain Treatment
RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement
The Environment Within: A Possible Link Identified Between Plasma Microbial Translocation & Autoantibody Development in 1st Degree Relatives of SLE Patients
PCSK9 Inhibitors May Lower Cholesterol in Patients with Statin-Associated Immune-Mediated Necrotizing Myopathy
Rituximab as Maintenance Therapy for Difficult-to-Treat SLE
Biologics May Prevent Cardiovascular Events in RA Patients
Lenabasum for Diffuse Cutaneous Systemic Sclerosis
Biosimilar Prescribing Habits in the VA & Academic Settings
- 1
- 2
- 3
- …
- 9
- Next Page »